Parabolic Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 20	Mar ' 18	Mar ' 17	Mar ' 16	Mar ' 15

Sources of funds

Owner's fund

Equity share capital

61.89

61.89

61.89

61.89

61.89

Share application money

-

26.00

26.00

26.00

26.00

Preference share capital

-

-

-

-

-

Reserves & surplus

-978.27

-934.22

-877.22

-769.15

-283.96

Loan funds

Secured loans

156.27

948.78

943.69

937.47

925.00

Unsecured loans

-

35.33

35.78

34.28

32.49

Total

-760.11

137.78

190.14

290.49

761.42

Uses of funds

Fixed assets

Gross block

283.44

480.39

482.00

482.74

485.35

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

154.02

133.16

111.55

90.22

Net block

283.44

326.37

348.84

371.19

395.13

Capital work-in-progress

-

6.52

6.52

6.52

6.52

Investments

6.34

6.34

6.33

6.33

6.32

Net current assets

Current assets, loans & advances

58.54

79.72

131.69

192.97

542.16

Less : current liabilities & provisions

1,108.43

281.16

303.24

286.51

188.72

Total net current assets

-1,049.89

-201.45

-171.54

-93.55

353.45

Miscellaneous expenses not written

-

-

-

-

-

Total

-760.11

137.78

190.14

290.49

761.42

Notes:

Book value of unquoted investments

-

6.34

6.33

6.33

6.32

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

6.25

-

-

8.33

Number of equity sharesoutstanding (Lacs)

618.90

618.92

618.92

618.92

618.92